Jenburkt Pharmaceuticals

1,050.00
-29.30
(-2.71%)
Market Cap
463.37 Cr
EPS
58.86
PE Ratio
15.17
Dividend Yield
1.42 %
Industry
Healthcare
52 Week High
1,375.00
52 Week Low
730.00
PB Ratio
3.02
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,612.98
79.83
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,233.96
25.11
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.09
60.42
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,516.96
52.60
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.82
#1 18.66
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.01
33.50
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.53
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.61
20.72
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.05
47.82
6,097.20
10.80
1,201
16.01
45.94
Growth Rate
Revenue Growth
3.31 %
Net Income Growth
5.69 %
Cash Flow Change
-52.38 %
ROE
-10.89 %
ROCE
-9.60 %
EBITDA Margin (Avg.)
3.00 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
87
96
106
118
126
123
114
129
142
147
156
Expenses
70
77
84
91
98
99
90
97
106
109
110
EBITDA
17
19
23
27
28
24
24
32
36
38
45
Operating Profit %
18 %
18 %
19 %
21 %
20 %
17 %
18 %
22 %
22 %
23 %
26 %
Depreciation
3
2
2
2
1
2
2
2
2
2
3
Interest
0
0
0
0
0
1
1
0
0
0
0
Profit Before Tax
14
17
21
25
27
21
22
30
33
35
43
Tax
5
6
7
8
7
6
5
8
8
9
11
Net Profit
10
11
14
17
20
15
17
22
25
26
31
EPS in ₹
20.75
23.18
29.05
37.50
43.14
32.40
35.96
48.58
53.90
58.86
71.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
61
58
76
78
103
104
121
143
142
165
Fixed Assets
12
12
11
10
10
12
11
11
10
10
Current Assets
49
45
64
66
90
90
80
76
81
110
Capital Work in Progress
0
0
0
0
1
0
0
0
1
1
Investments
0
0
2
5
5
4
7
8
11
17
Other Assets
49
46
64
63
87
88
104
123
119
137
Total Liabilities
61
58
76
78
103
104
121
143
142
165
Current Liabilities
24
14
18
13
23
20
18
21
16
16
Non Current Liabilities
4
4
4
3
3
5
5
4
4
4
Total Equity
33
40
54
61
78
80
99
117
122
145
Reserve & Surplus
29
36
50
57
73
75
94
113
118
141
Share Capital
5
5
5
5
5
5
5
5
4
4

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
11
2
1
-1
0
1
0
3
-1
1
Investing Activities
1
-0
-10
1
-11
-3
-19
-1
3
-1
Operating Activities
9
8
10
16
13
15
20
9
17
8
Financing Activities
1
-5
1
-18
-2
-11
-1
-6
-21
-7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.73 %
45.97 %
47.56 %
47.56 %
47.42 %
47.39 %
47.23 %
46.71 %
46.71 %
46.69 %
46.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
0.12 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.30 %
42.77 %
42.81 %
41.55 %
41.28 %
41.33 %
40.77 %
41.24 %
40.37 %
41.12 %
41.48 %
41.99 %
42.65 %
43.39 %
43.56 %
43.43 %
43.55 %
Others
9.97 %
11.49 %
11.46 %
12.72 %
12.99 %
12.94 %
13.50 %
12.79 %
12.08 %
11.32 %
11.10 %
10.62 %
10.11 %
9.90 %
9.73 %
9.76 %
9.66 %
No of Share Holders
6,825
6,873
6,626
6,116
6,053
6,016
5,896
5,784
5,611
5,741
5,872
6,021
6,316
6,419
6,628
6,901
6,987

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 8.1 9 10.2 8.1 10.2 12 14.4 15.3 0.00
Dividend Yield (%) 0.00 1.32 1.78 3.21 2.03 1.8 1.82 2.09 1.51 0.00

Corporate Action

Announcements

Disclosures Pursuant To SEBI Circular Dated 10Th August 2021 :"Not A Large Corporate"8 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Closure of Trading WindowMar 24, 2025
Intimation Of Acquisition Of Land Close To The Existing Plant At Sihor Gujarat.Mar 03, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 25, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2025
Integrated Filing (Financial)Jan 28, 2025
Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December 2024.Jan 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 28Th January 2025 Inter-Alia To Approved Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St DecemJan 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 21, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company.Jan 20, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Closure of Trading WindowDec 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 06, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today On 05-11-2024, Inter-Alia To Approved Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2024.Nov 05, 2024
Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2024.Nov 05, 2024
Board Meeting Intimation for Board Meeting Intimation For Inter-Alia, To Take On Record The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2024.Oct 28, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Closure of Trading WindowSep 23, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 17, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 08, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportJul 31, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2024
Proceedings Of The 39Th Annual General Meeting Held On Today I.E. 30Th July, 2024.Jul 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 27, 2024
Board Meeting Outcome for Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2024.Jul 26, 2024
Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2024.Jul 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 19, 2024
Board Meeting Intimation for Consideration And Approval Of The Standalone Unaudited Financial Results Of The Company For The Quarter Ended On 30Th June, 2024.Jul 18, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 15, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 03, 2024
Reg. 34 (1) Annual Report.Jul 02, 2024
Closure of Trading WindowJun 22, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 28, 2024
Intimantion Of Book Closure Date And Cut-Off DateMay 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th May, 2024May 28, 2024
Standalone Audited Financial Results For The Quarter And Financial Year Ended On 31St March, 2024.May 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2024
Board Meeting Intimation for Audited Results For The Quarter And Financial Year Ended On 31.03.2024 And To Consider Recommendation Of Dividend, If Any.May 18, 2024
Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015.Apr 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateApr 24, 2024
Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulatins 2015 For The FY Ended On 31St March, 2024.Apr 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 12, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementApr 12, 2024
Disclosures Pursuant To SEBI Circular Dated 10Th August, 2021 :Not A Large CorporateApr 08, 2024

Technical Indicators

RSI(14)
Neutral
51.22
ATR(14)
Volatile
46.66
STOCH(9,6)
Neutral
61.15
STOCH RSI(14)
Neutral
32.55
MACD(12,26)
Bullish
2.47
ADX(14)
Strong Trend
26.62
UO(9)
Bearish
61.52
ROC(12)
Uptrend And Accelerating
1.39
WillR(14)
Neutral
-57.57